Navigation Links
Shire to Present New Scientific Data on its ADHD Treatments at a Major Psychiatric Meeting
Date:10/22/2007

octor before using DAYTRANA if the child: is being treated for or has symptoms of depression (e.g. sadness, worthlessness, or hopelessness) or bipolar disorder; has family history of tics; has abnormal thoughts or visions, hears abnormal sounds, or has been diagnosed with psychosis; has had seizures or abnormal EEGs; has or has had high blood pressure; exhibits aggressive behavior or hostility. Tell your doctor immediately if the child develops any of these conditions/symptoms while using Daytrana.

In clinical studies, side effects were generally mild to moderate. The most common side effects reported with DAYTRANA were decreased appetite, sleeplessness, sadness/crying, twitching, weight loss, nausea, vomiting, tics, and affect lability (mood swings). Aggression, new abnormal thoughts/behaviors, mania, and growth suppression have been associated with use of drugs of this type. Tell your doctor if the child has blurred vision while using DAYTRANA.

Abuse of DAYTRANA can lead to dependence.

DAYTRANA should be applied daily to clean, dry skin, which is free of any cuts or irritation. Skin irritation or allergic skin rash may occur.

For Full Prescribing Information go to http://www.DAYTRANA.com.

SHIRE PLC

Shire's strategic goal is to become the leading specialty biopharmaceutical company that focuses on meeting the needs of the specialist physician. Shire focuses its business on attention deficit and hyperactivity disorder (ADHD), human genetic therapies (HGT), gastrointestinal (GI) and renal diseases. The structure is sufficiently flexible to allow Shire to target new therapeutic areas to the extent opportunities arise through acquisitions. Shire's in-licensing, merger and acquisition efforts are focused on products in niche markets with strong intellectual property protection either in the US or Europe. Shire believes that a carefully selected portfolio of products with strategicall
'/>"/>

SOURCE Shire plc
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine news :

1. Wrong Vaccination given during surgery in Derbyshire
2. More Study On Side Effects of ADHD Drug Needed: Shire Pharmaceuticals
3. Yorkshire hit by a different ball game: fish disease
4. The Lachlan Shire Council To Fund GP For Condobolin Health Service
5. Shire Developed DAYTRANA – The First Medication to Treat ADHD Symptom
6. Poor Health of people in Central Goldfields Shire, reports The Victorian Burden of Disease
7. Surgeons Presented Guidelines For Postoperative Atrial Fibrillation
8. Researchers Present Ways To Reduce The Risk Of Dementia
9. Researchers Present Data Regarding The Efficiency Of Herbs
10. Critically Ill Patients More At Risk Of Infection If Glucose Is Present In Their Lung Secretions
11. Ovarian Cancer Presents ‘Target Symptoms’ Six Months Before Diagnosi
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/9/2008)... finds more than 350 common sets of genes in patie...thDay News) -- Genetic activity in breast cancer c...s tend to more aggressive when they strike at a yo...younger women do worse than older women," said sen...of the clinical trials program in breast cancer at...
(Date:7/9/2008)...rtnership Integrates In-Store and Online Marketing...r Experience, PITTSBURGH and NEW YORK, July 9 /PR...on, ("GNC"), the largest global specialty retailer... ), the leading source of,health information, toda...increase consumer awareness and understanding of t...
(Date:7/9/2008)...ETHESDA, Md., July 9 /PRNewswire/ -- leViv, Inc. ...exclusively on nutrition and lifestyle programs fo...programs today. The new,programs include 28-days o...per day -- over 110 items in every order), online ...ucational resources, professional advice,news, he...
(Date:7/9/2008)...astfeeding.com adds to its unparalleled content on... Center,: 1400 professional articles on child, hea...s and sleep walking., BOULDER, Colo., July 9 /PRN...source with ,Everything for the New Mom, improves ...with over 1400 doctor-reviewed,professional articl...
Breaking Medicine News(10 mins):Health News:Gene Activity May Explain Deadlier Breast Cancers Among Younger Women 2Health News:Gene Activity May Explain Deadlier Breast Cancers Among Younger Women 3Health News:GNC and WebMD Announce Agreement To Provide Consumers with Health and Nutritional Information While Promoting the Benefits of a Healthy Lifestyle 2Health News:GNC and WebMD Announce Agreement To Provide Consumers with Health and Nutritional Information While Promoting the Benefits of a Healthy Lifestyle 3Health News:leViv Launches First Meal Programs Specifically Designed for Taste and Health 2Health News:leViv Launches First Meal Programs Specifically Designed for Taste and Health 3Health News:Breastfeeding.com Becomes a Premier Resource on Child Health 2
...e have discovered a tiny bacterium that could one ...phenyls (PCBs) from our environment//. The organis... detoxify commercial PCB compounds on site — witho... will appear in the April 15 issue of Applied and ...
...day has indicated the need for a cardiac departmen...cunae// in the care meted out to patients who have...kay Base Hospital. Mackay Base Hospital was found ...in 22 of the 26 categories but portrayed some worr...
...Hospital have discovered previously unsuspected mu...ric acute lymphoblastic leukemia (ALL), // the mos...y suggests novel methods for treating pediatric AL...ion of unsuspected mutations in adult cancers. &...
...im facts to state. The study estimates that more t...tism// and that it also takes more than two years ...n addition, around 125,000 Australians suffer from...d communication problems, social interaction and s...
Other Medicine News:Health News:Bacterium Could Treat PCBs Without the Need for Dredging 2Health News:Major Gene Study Uncovers Secrets of Leukemia 2Health News:Major Gene Study Uncovers Secrets of Leukemia 3
(Date:7/7/2008)...s scientific evidence supporting accuracy of, it...ajor international co...ly 7 /- Molecular,Biometrics, LLC, a ...el,clinical tools for applications in personalized... function in health and disease, presented data fr...
(Date:7/7/2008)...- Biopure Corporation,(Nasd...sions with the Food,and Drug Administration (FDA) ...r a new clinical trial of Hemopure(R) [hemoglobin ... proposed to study use of Hemopure,in patients suf...efuse,transfusion with blood components. Currently...
(Date:7/6/2008)...f Assay Submitted for FDA Clearance, SAN DIEGO, J...segment,of BD (Becton, Dickinson and Company) (NYS...D GeneOhm(TM) Cdiff molecular assay for the rapid ...nfection (CDI). It is the first CDI,diagnostic tes... one test,procedure. BD has also submitted this as...
(Date:7/3/2008)...Newswire-USNewswire/ -- All newborn infants,should...resent at birth,according to a new recommendation... recommendation and the accompanying summary of ev... Children whose hearing is impaired at birth, duri... with verbal and nonverbal communication and,socia...
Breaking Medicine Technology:Embryo Viability Studies Support Utility of Novel, Metabolomic Profiling Technology 2Embryo Viability Studies Support Utility of Novel, Metabolomic Profiling Technology 3Embryo Viability Studies Support Utility of Novel, Metabolomic Profiling Technology 4Biopure Announces Meeting With FDA 2Biopure Announces Meeting With FDA 3BD Announces CE Marking of a New Molecular Test to Diagnose Patients with Clostridium difficile Infections 2BD Announces CE Marking of a New Molecular Test to Diagnose Patients with Clostridium difficile Infections 3Task Force Recommends Screening for Hearing Loss in All Newborns 2Task Force Recommends Screening for Hearing Loss in All Newborns 3Phase II Study of Zevalin 28R 29 Consolidation Following Fludarabine and Mitoxantrone Chemotherapy Results in 100 Percent Complete Remission Rate and 1233 1Phase II Study of Zevalin 28R 29 Consolidation Following Fludarabine and Mitoxantrone Chemotherapy Results in 100 Percent Complete Remission Rate and 1233 2Phase II Study of Zevalin 28R 29 Consolidation Following Fludarabine and Mitoxantrone Chemotherapy Results in 100 Percent Complete Remission Rate and 1233 3Phase II Study of Zevalin 28R 29 Consolidation Following Fludarabine and Mitoxantrone Chemotherapy Results in 100 Percent Complete Remission Rate and 1233 4Phase II Study of Zevalin 28R 29 Consolidation Following Fludarabine and Mitoxantrone Chemotherapy Results in 100 Percent Complete Remission Rate and 1233 5Ovarian cancer risk not affected by alcohol and smoking but reduced by caffeine 9872 1Ovarian cancer risk not affected by alcohol and smoking but reduced by caffeine 9872 2Super Thin Drug Free Coating Hides Stent as It Unblocks Heart Arteries 9870 1Super Thin Drug Free Coating Hides Stent as It Unblocks Heart Arteries 9870 2Super Thin Drug Free Coating Hides Stent as It Unblocks Heart Arteries 9870 3Super Thin Drug Free Coating Hides Stent as It Unblocks Heart Arteries 9870 4Deli Chef Tri Bean Salad Recalled From Some Kroger Stores 9868 1
...Point Therapeutics, Inc.,(NASDAQ: POTP) today repo... at the 2007 Annual Meeting of the American,Associ...os Angeles,California, April 14-18, 2007. The AAC...es on talabostat,s novel mechanism of action., Add...follows: , Presentation Date and Time: Monday, Apr...
... - Ascenta Therapeutics,Inc. announced today that...ing compounds will be featured in three oral,prese...week,s 2007,Annual Meeting of the American Associa... Angeles, California April 14-18, 2007., Ascenta,s...t the,"High Impact Late-Breaking Research 1" sessi...
Other Medicine Technology:Ascenta Therapeutics Highlights Multiple Data Presentations at,Upcoming AACR Annual Meeting 2Ascenta Therapeutics Highlights Multiple Data Presentations at,Upcoming AACR Annual Meeting 3Ascenta Therapeutics Highlights Multiple Data Presentations at,Upcoming AACR Annual Meeting 4Ascenta Therapeutics Highlights Multiple Data Presentations at,Upcoming AACR Annual Meeting 5Ascenta Therapeutics Highlights Multiple Data Presentations at,Upcoming AACR Annual Meeting 6
...0 provides a new screening, diagnostic, treatment ...the medical management of sleep-related breathing ...l the unmet need for an ambulatory, reliable, pati...cessible to the great number of OSA sufferers, and...
...ulin is the C-terminal cleavage product produced d...mature insulin molecule. Although the C-peptide of... significant liver or extra-renal metabolism and t...han insulin [1]. In addition, C-peptide assays may...
...7-Hydroxy-4-androstene-3-one), a C19 steroid, is o... [1]. In postpubertal males, testosterone is secre...nt derived from peripheral conversion of androsten...that over 50% of serum testosterone is derived fro...
...s the primary active hormone synthesized within th... synthesized via a series of steps involving: (i) ...nation of tyrosine residues in the thyroglobulin s...e and 3,5-diiodotyrosine (MIT and DIT), and (iii) ...
Medicine Products: